Zoetis (ZTS) EBITDA (2012 - 2026)
Zoetis (ZTS) posted quarterly EBITDA of $833.0 million for Q1 2026, down 1.3% year-over-year from $844.0 million in Q1 2025, and down 0.95% quarter-over-quarter from $841.0 million in Q4 2025.
Zoetis (ZTS) EBITDA (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported EBITDA for 15 consecutive years, with $833.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA fell 1.3% year-over-year to $833.0 million; the TTM figure through Mar 2026 stood at $3.6 billion (up 4.01% YoY), while the FY2025 annual figure was $3.7 billion, up 5.63% from the prior year.
- EBITDA eased to $833.0 million in Q1 2026 per ZTS's latest filing, from $841.0 million in the prior quarter.
- Across five years, EBITDA topped out at $992.0 million in Q2 2025 and bottomed at $728.0 million in Q4 2022.
- Historically, EBITDA has averaged $834.8 million across 5 years, with a median of $833.0 million in 2026.
- Annual changes were most pronounced in 2022 — EBITDA surged 62.67% — and 2023, when it retreated 10.14%.
- Zoetis' EBITDA stood at $728.0 million in 2022, then increased by 1.37% to $738.0 million in 2023, then rose by 7.99% to $797.0 million in 2024, then increased by 5.52% to $841.0 million in 2025, then declined by 0.95% to $833.0 million in 2026.
- Business Quant data shows ZTS's EBITDA at $833.0 million in Q1 2026, $841.0 million in Q4 2025, and $964.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 18.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 953.00 Mn |
| Mar 31, 2026 | 833.00 Mn |
| Dec 31, 2025 | 841.00 Mn |
| Sep 30, 2025 | 964.00 Mn |
| Jun 30, 2025 | 992.00 Mn |
| Mar 31, 2025 | 844.00 Mn |
| Dec 31, 2024 | 797.00 Mn |
| Sep 30, 2024 | 950.00 Mn |
| Jun 30, 2024 | 899.00 Mn |
| Mar 31, 2024 | 834.00 Mn |
| Dec 31, 2023 | 738.00 Mn |
| Sep 30, 2023 | 820.00 Mn |
| Jun 30, 2023 | 863.00 Mn |
| Mar 31, 2023 | 744.00 Mn |
| Dec 31, 2022 | 728.00 Mn |
| Sep 30, 2022 | 754.00 Mn |
| Jun 30, 2022 | 762.00 Mn |
| Mar 31, 2022 | 828.00 Mn |
| Dec 31, 2021 | 632.00 Mn |
| Sep 30, 2021 | 759.00 Mn |